Disease, Signaling and Drug Targets
The Elective Module 'Disease, Signaling and Drug Targets' (DSDT) is similar to the Minor Computational Approaches to Disease, Signaling and Drug Targets and consists of the Courses listed below. The focus of this Elective Module is slightly shifted towards dissection of cellular signaling responses in disease as well as using stem cells in drug safety through two ‘wet lab’ projects and has a little less computational components than the Minor.
Admission to the Elective Module is restricted to students of the BSc programme Bio-Pharmaceutical Sciences who have successfully completed 60 EC of which at least two practical courses. The module as a whole has been approved by the Board of Examiners BFW/BPS; should a student replace any of the Courses, he/she will need prior approval from the Board of Examiners BFW/BPS.
The maximum number of BFW students admitted in the academic year 2022-2023 has been set at 40, admission occurs in the order of enrollment in uSis. Enrollment in uSis is open from April 1st to June 15th 2022, using 4012KDSDTN and/or class number 1184.